|
Interagency Group on Alzheimer''s Disease and Related Dementias for implementation of the National Alzheimer''s Project Act
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA
|
NIA
|
This interagency group was established by HHS in response to the Congressional directive to address Alzheimer disease. Under the National Alzheimer’s Project Act, HHS created three sub-groups on Research, Long Term Services, and Clinical Services. The Veteran’s Administration, National Science Foundation, and Department of Defense are also involved in this effort.
|
|
Interagency Midazolam Product Coordination Team
|
Committee, Work group, Advisory group, or Task Force
|
FDA, OS
|
NINDS
|
A collaboration led by the Department of Health and Human Services (HHS) to facilitate activities, both research and regulatory, related to the Food and Drug Administration (FDA) approval of midazolam for use in treating nerve agent exposure.
|
|
Interagency Middle Eastern respiratory syndrome MERS-CoV Working Group on Medical Countermeasures
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID
|
The Working Group focuses on potential MERS-CoV countermeasures, to include therapeutics (i.e., antivirals, monoclonal antibodies, and others) and vaccines. The working group was asked to assess the following:
a) inventory of potential therapeutics (and vaccines) under development/investigation and by what groups
b) how far along are they in pre-clinical development (in-vitro, animal studies/mice/non- human primates) and what data are available
c) timelines for animal studies and scale-up including when human trials (phase 1, phase 2, open-label studies) can be started
d) safety and regulatory issues for IND, EUA, and clinical studies
e) prioritization for clinical trials based upon pre-clinical data and scientific assessment of available data
|
|
Interagency Modeling and Analysis Group (IMAG)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIBIB, CSR, NCI, NHGRI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NLM, OD/DPCPSI/OBSSR
|
The Interagency Modeling and Analysis Group (IMAG) is comprised of program directors from nine government agencies in the U.S. including the National Institutes of Health (NIH), the National Science Foundation (NSF), Department of Energy (DOE), Department of Defense (DOD), the United States Department of Agriculture (USDA), the National Aeronautics and Space Administration (NASA), the United States Department of Veterans Administration (USDVA), the Food and Drug Administration (FDA), and the Intelligence Advanced Research Projects Activity (IARPA). The purpose of IMAG is to bring together program officers who have a shared interest in supporting modeling and analysis methods in biomedical, biological and behavioral systems. IMAG has promoted and supported a wide variety of modeling over the past 13 years, notably the multi-scale modeling (MSM) initiative, which was originally a multi-agency funding opportunity announcement and continued on by different IMAG agencies through separate funding opportunity announcements. The most recent MSM Consortium Meeting was held in September 2015.
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA
|
NINDS, NCCIH, NIDA, NIDCR, NINR
|
The Interagency Pain Research Coordination Committee is an Affordable Care Act mandated committee to coordinate pain research activities across the government.
|
|
Interagency Public Access Working Group
|
Other
|
ACL, AHRQ, CDC, FDA, OS
|
OD/OSP, OD/OER
|
On February 22, 2013, the Director of the White House Office of Science and Technology Policy (OSTP), Dr. John Holdren, issued a memorandum to all agency and department heads entitled, “Increasing Access to the Results of Federally Funded Scientific Research.” The memo directed federal agencies with more than $100 million in annual conduct of research and development to develop plans for increasing public access to peer-reviewed scientific publications and digital data resulting from federally funded research investments. Within HHS, six operating divisions and the Office of the Secretary meet this threshold. The HHS operating divisions have aligned their work through a common set of guiding principles and a framework around which they could develop implementation plans tailored to the needs of their research communities, taking into account their unique missions and legal authorities. OSTP also maintains federal-wide interagency working group.
|
|
Interagency Select Agent Review Group (ISARG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID, OD/OM/OB, OD/OSP
|
The Interagency Select Agent Review Group (ISARG), composed of members from the Centers for Disease Control and Prevention (CDC), the Department of Justice, the Department of State, the NIH-OD and BARDA advises the National Institute of Allergy and Infectious Diseases (NIAID) on whether facilities and procedures at NIAID-funded foreign research sites are comparable to those required by the Select Agent Regulations for domestic institutions before Select Agent work at the foreign site may proceed.
|
|
Interagency Task Force on Antimicrobial Resistance (ITFAR)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
The Interagency Task Force on Antimicrobial Resistance (ITFAR) is a coordinating committee within the U.S. government for research on antimicrobial resistance.
|
|
Interagency Workgroup on Child Abuse and Neglect
|
Committee, Work group, Advisory group, or Task Force
|
ACF
|
NICHD, CSR, NIAAA, NIDA, NIMH, NINDS, OD/DPCPSI/OBSSR
|
The overall goals of the FEDIAWG are:
• To provide a forum through which staff from relevant Federal agencies can communicate and exchange ideas concerning child maltreatment related programs and activities;
• To collect information about Federal child maltreatment activities; and
• To provide a basis for collective action through which funding and resources can be maximized.
|
|
Interagency Workgroup on Child Abuse and Neglect
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, CDC, IHS, SAMHSA
|
NIMH, NICHD, NIDA
|
The Federal Interagency Workgroup on Child Abuse and Neglect meets to provide a forum through which staff from relevant federal agencies can communicate and exchange ideas concerning the prevention of child maltreatment and other related issues.
|